Concepedia

Syunji Yamazaki

SY

Statistics

Publications

4

Citations

288

H-Index

4

Active since

2004

Syunji Yamazaki is an author specializing in pharmacology, neuroscience, and parp inhibition.

Publications per year

2004–2004

4

Publications

4

Rational Approaches to Discovery of Orally Active and Brain-Penetrable Quinazolinone Inhibitors of Poly(ADP-ribose)polymerase

Kouji Hattori, Yoshiyuki Kido, Hirofumi Yamamoto et al. · Journal of Medicinal Chemistry · 2004 · 97 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia

Akinori Iwashita, Nobuteru Tojo, Shigeru Matsuura et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 83 citations

Medicine, Neuroscience, Pharmacology +17

Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3 H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease

Akinori Iwashita, Syunji Yamazaki, Kayoko Mihara et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 67 citations

Life Sciences, Neuroscience, Pharmacology +17

A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice

Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 41 citations

Medicine, Neuroscience, Pharmacology +17

1–4 of 4